These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23176522)

  • 21. Nonlinear dimensionality reduction and mapping of compound libraries for drug discovery.
    Reutlinger M; Schneider G
    J Mol Graph Model; 2012 Apr; 34():108-17. PubMed ID: 22326864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expanding the medicinally relevant chemical space with compound libraries.
    López-Vallejo F; Giulianotti MA; Houghten RA; Medina-Franco JL
    Drug Discov Today; 2012 Jul; 17(13-14):718-26. PubMed ID: 22515962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hole filling and library optimization: application to commercially available fragment libraries.
    An Y; Sherman W; Dixon SL
    Bioorg Med Chem; 2012 Sep; 20(18):5379-87. PubMed ID: 22503740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotography for multi-target SAR analysis in the context of biological pathways.
    Lounkine E; Kutchukian P; Petrone P; Davies JW; Glick M
    Bioorg Med Chem; 2012 Sep; 20(18):5416-27. PubMed ID: 22405595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. inSARa: intuitive and interactive SAR interpretation by reduced graphs and hierarchical MCS-based network navigation.
    Wollenhaupt S; Baumann K
    J Chem Inf Model; 2014 Jun; 54(6):1578-95. PubMed ID: 24850242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enumeration of 166 billion organic small molecules in the chemical universe database GDB-17.
    Ruddigkeit L; van Deursen R; Blum LC; Reymond JL
    J Chem Inf Model; 2012 Nov; 52(11):2864-75. PubMed ID: 23088335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methods for combinatorial and parallel library design.
    Schnur DM; Beno BR; Tebben AJ; Cavallaro C
    Methods Mol Biol; 2011; 672():387-434. PubMed ID: 20838978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein structure similarity clustering and natural product structure as guiding principles in drug discovery.
    Koch MA; Waldmann H
    Drug Discov Today; 2005 Apr; 10(7):471-83. PubMed ID: 15809193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A similarity-based data-fusion approach to the visual characterization and comparison of compound databases.
    Medina-Franco JL; Maggiora GM; Giulianotti MA; Pinilla C; Houghten RA
    Chem Biol Drug Des; 2007 Nov; 70(5):393-412. PubMed ID: 17927720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Building structure-activity insights through patent mining.
    Tu M; Pfefferkorn JA; Guzman-Perez A; Filipski KJ
    Pharm Pat Anal; 2012 Nov; 1(5):545-54. PubMed ID: 24236924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current parallel chemistry principles and practice: application to the discovery of biologically active molecules.
    Edwards PJ
    Curr Opin Drug Discov Devel; 2009 Nov; 12(6):899-914. PubMed ID: 19894197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design of a three-dimensional multitarget activity landscape.
    de la Vega de León A; Bajorath J
    J Chem Inf Model; 2012 Nov; 52(11):2876-83. PubMed ID: 23113585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single R-Group Polymorphisms (SRPs) and R-cliffs: an intuitive framework for analyzing and visualizing activity cliffs in a single analog series.
    Agrafiotis DK; Wiener JJ; Skalkin A; Kolpak J
    J Chem Inf Model; 2011 May; 51(5):1122-31. PubMed ID: 21504183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Broad coverage of commercially available lead-like screening space with fewer than 350,000 compounds.
    Baell JB
    J Chem Inf Model; 2013 Jan; 53(1):39-55. PubMed ID: 23198812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A relational learning approach to Structure-Activity Relationships in drug design toxicity studies.
    Camacho R; Pereira M; Costa VS; Fonseca NA; Adriano C; Simões CJ; Brito RM
    J Integr Bioinform; 2011 Sep; 8(3):182. PubMed ID: 21926445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extending the activity cliff concept: structural categorization of activity cliffs and systematic identification of different types of cliffs in the ChEMBL database.
    Hu Y; Bajorath J
    J Chem Inf Model; 2012 Jul; 52(7):1806-11. PubMed ID: 22758389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mining a chemical database for fragment co-occurrence: discovery of "chemical clichés".
    Lameijer EW; Kok JN; Bäck T; Ijzerman AP
    J Chem Inf Model; 2006; 46(2):553-62. PubMed ID: 16562983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computational analysis of activity and selectivity cliffs.
    Peltason L; Bajorath J
    Methods Mol Biol; 2011; 672():119-32. PubMed ID: 20838966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthetic library design.
    Huwe CM
    Drug Discov Today; 2006 Aug; 11(15-16):763-7. PubMed ID: 16846805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.